FRG Family Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

FRG Family Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,596	Closed	-$70.1K	–	171
2024 Q1	$70.1K	Buy	+1,596	New	+$81.3K	0.01%	183
2023 Q2	–	Sell	-2,916	Closed	-$202K	–	140
2023 Q1	$202K	Hold	2,916	–	–	0.05%	140
2022 Q4	$210K	Sell	2,916 -70	-2%	-$5.28K	0.05%	136
2022 Q3	$212K	Hold	2,986	–	–	0.05%	133
2022 Q2	$230K	Sell	2,986 -215	-7%	-$16.4K	0.05%	133
2022 Q1	$234K	Sell	3,201 -100	-3%	-$6.71K	0.05%	137
2021 Q4	$206K	Sell	3,301 -8,545	-72%	-$501K	0.04%	142
2021 Q3	$701K	Sell	11,846 -815	-6%	-$53.7K	0.14%	90
2021 Q2	$846K	Sell	12,661 -2,515	-17%	-$164K	0.16%	86
2021 Q1	$958K	Sell	15,176 -800	-5%	-$49.8K	0.2%	74
2020 Q4	$991K	Sell	15,976 -155	-1%	-$9.53K	0.22%	71
2020 Q3	$973K	Buy	16,131 +3,280	+26%	+$197K	0.24%	71
2020 Q2	$756K	Buy	+12,851	New	+$769K	0.2%	78

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FRG Family Wealth Advisors's BMY Position: Q2 2024 in Review

FRG Family Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 1,596 shares — an estimated $70.1K sold.

FRG Family Wealth Advisors first reported a position in BMY in Q2 2020 and held it in 13 quarters. The position peaked at $991K in Q4 2020. 2,153 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

FRG Family Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
FRG Family Wealth Advisors sold 1,596 Bristol-Myers Squibb shares in Q2 2024, an estimated $70.1K.
FRG Family Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 13 quarters.
FRG Family Wealth Advisors's Bristol-Myers Squibb position peaked at $991K in Q4 2020.
2,153 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on FRG Family Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.